AMGN vs ECOR · P/E 24, rev $10.05B vs rev $19.0M
Amgen Inc (AMGN) versus Electrocore LLC (ECOR) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Electrocore LLC (ECOR) is a medical devices company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported ECOR revenue for 2026-06-30 was $19.0M. Net income was -$8.3M. Revenue was up 98.6% from 2026-03-31 to 2026-06-30. ECOR currently screens at market cap $45.3M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. ECOR currently screens at market cap $45.3M.
Not investment advice. Open the AMGN and ECOR stock pages for the full models.
Not investment advice.